Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|September 16, 2008
Novel opportunities for thymidylate metabolism as a therapeutic targetPeter M Wilson, William Fazzone, Melissa J LaBonte, et al.
Molecular Cancer Therapeutics|December 17, 2011
Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancerPeter M Wilson, Melissa J LaBonte, Heinz-Josef Lenz, et al.
BMC Medical Genomics|December 2, 2009
DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell linesMelissa J LaBonte, Peter M Wilson, William Fazzone, et al.
Nucleic Acids Research|May 18, 2011
A novel fluorescence-based assay for the rapid detection and quantification of cellular deoxyribonucleoside triphosphatesPeter M Wilson, Melissa J Labonte, Jared Russell, et al.
The FEBS Journal|September 23, 2024
Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspectiveHadil Suleiman, Alexandra Emerson, Peter M Wilson, et al.
International Journal of Cancer|June 19, 2009
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38Melissa J LaBonte, Philipp C Manegold, Peter M Wilson, et al.
Investigational New Drugs|January 10, 2013
Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancerPeter M Wilson, Melissa J Labonte, Shelby C Martin, et al.
Cancer Research|April 6, 2011
The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer modelsMelissa J LaBonte, Peter M Wilson, Will Fazzone, et al.
Plos One|June 2, 2011
Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathwayLeanne Stevenson, Wendy L Allen, Irina Proutski, et al.
Cancer Research|March 3, 2006
Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancerJohn Boyer, Wendy L Allen, Estelle G McLean, et al.
Pageof 4